Gates Biomanufacturing Facility

GBF GOES WELL BEYOND STANDARD DEFINITION

Closely collaborating with our clients for effective translation of new agents into ground breaking, first in human, phase I and II studies.

ONE-OF-A-KIND MEDICAL ECOSYSTEM

Linking researchers, clinicians, and a Good Manufacturing Practice facility.

GBF STAFF IS DEEPLY INVESTED

Moving science to the clinic and out into the world where it can make a difference.

AN ACADEMIC GMP WITH A CLEAR FOCUS

For biomedical researchers and biotechnology companies hoping to transition laboratory discoveries to cell therapies and protein biologics suitable for human clinical trials, a partnership with Gates Biomanufacturing Facility (GBF) goes well beyond what the term “manufacturing facility” might indicate. GBF was conceived, built and staffed as an academic Good Manufacturing Practice (GMP) aiming to closely collaborate with our clients for effective translation of new agents into ground breaking, first in human, phase I and II studies. The facility excels in the pre-clinical/process development setting to facilitate scale up for human use, reproducibility, product quality control, IND submission, meticulous materials management, state of the art GMP manufacturing. This technical capability is implement as a partnership with the help of a dedicated project management team.

BENEFITS OF PARTNERSHIPS

GBF’s clear focus, energy, autonomy and resources, are all byproducts of its partnership with a major research university, as well as its proximity to and close ties with the hospitals and clinics of the medical hub of the Mountain West.

FROM BENCH TO BEDSIDE

For GBF, the saying, “from bench to bedside” is more than a slogan. It’s an apt description of its ability, as a uniquely positioned Phase 1 CDMO, to develop new science into preclinical batches that can quite literally be walked to trials performed at The University of Colorado Hospital or Children’s Hospital Colorado.

VISION

An established and nationally recognized academic leader in development and manufacture of groundbreaking cellular, gene-modified and protein biologic therapies to enable pivotal human clinical trials for treatment of unmet medical needs.

GATES INSTITUTE 

“In my mind, it’s about working with doctors, researchers, scientists, patients to do clinical trials that will be either cures or help a body heal itself or will extend life or the quality of life.”

~Diane Gates Wallach, Gates Institute Advisory Board

RECENT GATES BIOMANUFACTURING FACILITY NEWS

Gates Biomanufacturing Facility Deploys CAR T-Cell Process Improvement

Since receiving FDA approval in 2017, chimeric antigen [...]

Behind the Scenes of a CAR T-Cell Trial

Enrollment has begun for a new phase 1 [...]

New CAR T-Cell Trial Enrolling Patients at CU Anschutz

Enrollment has begun for a new phase 1 [...]